Sun Pharma appoints Aalok Shanghvi as Chief Operating Officer

Sun Pharmaceutical Industries has appointed Aalok Shanghvi as its Chief Operating Officer (COO). The company announced the designation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Shanghvi has been with Sun Pharma since 2006, holding various roles across marketing, research and development (R&D), project management, procurement, and communications. In 2014, he became Head of Emerging Markets, overseeing business operations in 80 countries, including Africa, the Middle East, Asia-Pacific, Eastern Europe, the Commonwealth of Independent States (CIS), and Latin America. The Emerging Markets division contributes approximately 18 per cent to Sun Pharma’s global revenue.

In addition to leading the Emerging Markets segment, Shanghvi later took on responsibilities in Global Generic R&D, Global Business Development (Generics), Operations, and Active Pharmaceutical Ingredients (API). Since June 2023, he has been serving as a Whole-time Director at Sun Pharma.

Shanghvi holds a degree in Cellular and Molecular Biology from the University of Michigan – Ann Arbor.

Related Posts

  • Pharma
  • May 9, 2025
  • 115 views
Diabetes drug shows promise for treating prostate cancer

An international team of scientists led by the Medical University of Vienna has identified similarities in the mechanisms of diabetes and cancer: as the researchers show, the protein PPARγ, which…

  • Pharma
  • May 9, 2025
  • 115 views
Biocon Q4 net profit surges 153%, biosimilars, generics drive growth

Biocon, India’s leading biopharmaceutical company, reported a 153 percent year-on-year (YoY) jump in net profit for the fourth quarter of FY25, led by strong performances in its biosimilars and generics…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Diabetes drug shows promise for treating prostate cancer

Diabetes drug shows promise for treating prostate cancer

Biocon Q4 net profit surges 153%, biosimilars, generics drive growth

Biocon Q4 net profit surges 153%, biosimilars, generics drive growth

India puts in place a health emergency plan for Jammu and Kashmir, transports portable hospitals to Poonch, Uri

India puts in place a health emergency plan for Jammu and Kashmir, transports portable hospitals to Poonch, Uri

CEO speaks: India’s AI-Powered Pharma Revolution: The Next Big Wave in Healthcare

CEO speaks: India’s AI-Powered Pharma Revolution: The Next Big Wave in Healthcare